Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Estée Lauder $2 billion senior notes offering
The investment-grade notes are due 2028, 2033 and 2053
Integral Ad Science $165.6 million secondary offering
The stock is listed on the Nasdaq Global Market
Franchise Group acquisition financing
We are advising the lead arranger on the acquisition financing
Hayward Holdings $286 million secondary offering
The stock is listed on the New York Stock Exchange
Beyond Meat $200 million at-the-market offering
The stock offering is SEC-registered
Comcast $5 billion notes offering and $2.9 billion cash tender offers
We advised Comcast in connection with the transactions
Livent $10.6 billion merger of equals with Allkem
We are advising Livent on the transaction
General Motors Financial $400 million senior notes offering
The investment-grade notes are due 2026
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021